Steve currently serves as the chief executive officer and chairman of the board of Karuna Therapeutics. Prior to Karuna, he served as our president and chief executive officer. Additionally, he is a venture partner at Third Rock Ventures. Before joining Voyager, Steve was the founding director of the Appel Alzheimer’s Disease Research Institute, as well as professor of neuroscience, psychiatry and pharmacology at Weill Cornell Medical College. Preceding his appointment at Weill Cornell, Steve served in several key leadership roles at Eli Lilly, including president of the Lilly Research Laboratories, and vice president of discovery research and neuroscience research. Prior to Eli Lilly, Steve served as scientific director of the National Institute of Mental Health at NIHa and as medical director in the Commissioned Corps of the United States Public Health Service. He is an elected fellow of the American Association for the Advancement of Science and a member of the National Academy of Medicine of the National Academy of Sciences. Steve currently serves on the boards of Karuna Therapeutics, Sage Therapeutics and Alnylam Pharmaceuticals, and is a chairman of the board for the Foundation for the National Institutes of Health. He has authored or co-authored more than 550 papers and book chapters. Steve has a B.A. in biology and psychology from Tulane University and a M.S. and Doctor of Medicine from the Tulane University School of Medicine.